BioSpace News Archive

Cytek Biosciences, Inc. has signed an agreement with the Centre for Genomic Regulation and the Pompeu Fabra University to drive technological innovation and accelerate discoveries for the scientific community.

Viridian Therapeutics, Inc. announced the pricing of an underwritten public offering with gross proceeds of approximately $150.0 million.

Shanghai Junshi Biosciences Co., Ltd announced the publication of results from the prespecified interim analysis for event-free survival in patients with stage III non-Small Cell Lung Cancer of NEOTORCH in theJournal of the American Medical Association.

Globally operating CDMO committed to strengthening Germany as a research and production location Association grants Vetter extraordinary membership vfa recognizes the importance of pharmaceutical service providers in drug development and production Vetter serves on key vfa committees RAVENSBURG, Germany--( BUSINESS WIRE )-- Vetter, a leading globally operating contract development and manufacturing organization (CDMO), has joined the German Association o

Better Therapeutics Inc. announced the publication of health economic data for its prescription-only digital behavioral treatment for type 2 diabetes, AspyreRx.

Eurofins CDMO Alphora Inc., a Contract Drug and Manufacturing Organization based in Mississauga, Canada, is excited to announce the successful completion of its pilot-scale biologics development facility.

Smart Meter, the leading provider of cellular Remote Patient Monitoring solutions, has recently been granted two groundbreaking patents, expanding its position as a healthcare technology innovator.

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its products into the Japanese market.

Cardiff Oncology, Inc. today announced that the findings of the Phase 1b portion of the Phase 1b/2 study for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC) disclosed by Cardiff Oncology in August 2023 have been published in the peer-reviewed journal Clinical Cancer Research, a journal of the American Association for Cancer Research.

Epicore Biosystems today announced that it has received investment from Pegasus Tech Ventures (‘Pegasus’), a global venture capital firm based in Silicon Valley, and Denka Company Limited (‘Denka’), a Japan-based multinational technology and materials company.